Global, Regional, and National Burden of Chronic Myeloid Leukemia, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017
BackgroundWith the advent of tyrosine kinase inhibitors (TKIs), the prognosis of chronic myeloid leukemia (CML) seems to have dramatically improved over the last two decades. Accurate information of the global burden of CML is critical for direct health policy and healthcare resource allocation in t...
Main Authors: | Qingqing Lin, Liping Mao, Li Shao, Li Zhu, Qingmei Han, Honghu Zhu, Jie Jin, Liangshun You |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.580759/full |
Similar Items
-
The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017
by: Ming Yi, et al.
Published: (2020-06-01) -
Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study
by: Linghui Zhou, et al.
Published: (2019-10-01) -
Burden of headache disorders in China, 1990–2017: findings from the Global Burden of Disease Study 2017
by: Chengye Yao, et al.
Published: (2019-11-01) -
The global, regional, and national burden of pancreatitis in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
by: Guoqing Ouyang, et al.
Published: (2020-12-01) -
Global, Regional, and National Burden of Endometrial Cancer, 1990–2017: Results From the Global Burden of Disease Study, 2017
by: Shuang Zhang, et al.
Published: (2019-12-01)